Patents by Inventor Tetsuji Saito

Tetsuji Saito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11563403
    Abstract: To provide a coating material capable of forming a solar cell module excellent in the weather resistance, the power generation efficiency and the design, a cover glass, a solar cell module comprising the cover glass, and an outer wall material for building. The cover glass of the present invention is a cover glass comprising a glass plate and a layer containing a fluorinated polymer having units based on a fluoroolefin, on at least one surface of the glass plate, which has an average visible reflectance of from 10 to 100%, and an average near infrared transmittance of from 20 to 100%.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: January 24, 2023
    Assignees: AGC Inc., AGC GLASS EUROPE
    Inventors: Yu Onozaki, Tomohiro Sakai, Shun Saito, Noriyoshi Kayaba, Aichi Inoue, Tetsuji Irie
  • Patent number: 11190742
    Abstract: A projection apparatus according to the present invention, includes: a field programmable gate array (FPGA) configured to control projection; and at least one processor which functions as: a configuration unit configured to configure a circuit to be included in the FPGA to a circuit corresponding to a state of the projection apparatus.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: November 30, 2021
    Assignee: CANON KABUSHIKI KAISHA
    Inventors: Masaya Yagi, Takashi Asaka, Tetsuji Saito, Toru Koike
  • Patent number: 10839758
    Abstract: An image display apparatus according to the present invention includes: a display unit configured to display a moving image based on input moving image data; a determining unit configured to determine whether or not a specific reproduction operation related to a reproduction method of the moving image data has been performed; and a control unit configured to control display by the display unit so that display of a moving image of which brightness is higher than a first threshold is suppressed in a case where the specific reproduction operation has been performed.
    Type: Grant
    Filed: May 30, 2016
    Date of Patent: November 17, 2020
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Tetsuji Saito
  • Publication number: 20200344453
    Abstract: A projection apparatus according to the present invention, includes: a field progranmable gate array (FPGA) configured to control projection; and at least one processor which functions as: a configuration unit configured to configure a circuit to be included in the FPGA to a circuit corresponding to a state of the projection apparatus.
    Type: Application
    Filed: April 21, 2020
    Publication date: October 29, 2020
    Inventors: Masaya Yagi, Takashi Asaka, Tetsuji Saito, Toru Koike
  • Patent number: 10676438
    Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: June 9, 2020
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Kentaro Yashiro, Daisuke Wakamatsu, Tetsuji Saito
  • Publication number: 20200157050
    Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 21, 2020
    Applicant: Ono Pharmaceutical Co., Ltd.
    Inventors: Kentaro YASHIRO, Daisuke WAKAMATSU, Tetsuji SAITO
  • Patent number: 10657622
    Abstract: An information processing apparatus according to the present invention, includes: a first acquiring unit configured to acquire surface change information on magnitude of change of a projection surface onto which an image is projected; and a determining unit configured to determine, based on the surface change information, frame rate control information on a frame rate of image processing to allow the image to follow the projection surface.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: May 19, 2020
    Assignee: Canon Kabushiki Kaisha
    Inventor: Tetsuji Saito
  • Patent number: 10570093
    Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: February 25, 2020
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Kentaro Yashiro, Daisuke Wakamatsu, Tetsuji Saito
  • Patent number: 10519105
    Abstract: An object of the present invention is to provide a novel compound having a strong opening action with respect to KCNQ2-5 channels. A compound represented by the general formula (I) (wherein the definition of each group is as described in the specification) is provided. The compound represented by the general formula (I) has a strong opening action with respect to KCNQ2-5 channels, and therefore is useful as a prophylactic and/or therapeutic agent for a KCNQ2-5 channel-related disease (for example, dysuria, overactive bladder, or the like).
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: December 31, 2019
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kentaro Yashiro, Masashi Kato, Tetsuji Saito, Takuya Okada, Daisuke Wakamatsu, Adam James Davenport, Christopher Charles Stimson
  • Patent number: 10403233
    Abstract: An image processing apparatus according to the present invention, includes: a determination unit configured to determine, based on a layout of at least one image included in display image data, a display correspondence, which is a correspondence between a gradation value of the display image data and a display brightness in a case where a display unit displays an image based on the display image data; and an output unit configured to output to the display unit the display image data and information indicating the display correspondence.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: September 3, 2019
    Assignee: Canon Kabushiki Kaisha
    Inventor: Tetsuji Saito
  • Patent number: 10389894
    Abstract: An image processing apparatus comprises: a first generation unit that generates approximate light pattern by adjusting spatial frequency of an input image, and generates a projection image data based on the approximate light pattern; and a second generation unit that generates a print image data based on the input image, wherein the second generation unit generates the print image data so that a difference between the input image and an image for observation obtained by superimposing projection light projected based on the projection image data onto a printed matter printed based on the print image data is reduced.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: August 20, 2019
    Assignee: CANON KABUSHIKI KAISHA
    Inventors: Masanao Kurita, Shinya Oda, Masayoshi Sekine, Tetsuji Saito, Yasuo Suda
  • Publication number: 20190135755
    Abstract: Crystal polymorphism may exist in a crystalline compound. In the case where crystal polymorphism exists, depending on the crystal form, solubility, dissolution rate, stability against heat, light, humidity, etc. or the like is different. Accordingly, in the production of a pharmaceutical product, it is a very important task to select a crystal form of a drug substance most suitable for a disease indication and a dosage form. The present invention relates to novel crystal forms (A crystal, W crystal, and a hydrate crystal (H crystal)) of a compound I having a strong opening action with respect to KCNQ2-5 channels.
    Type: Application
    Filed: April 21, 2017
    Publication date: May 9, 2019
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kentaro YASHIRO, Hideomi KIJIMA, Daisuke WAKAMATSU, Tetsuji SAITO
  • Publication number: 20190127320
    Abstract: An object of the present invention is to provide a novel compound having a strong opening action with respect to KCNQ2-5 channels. A compound represented by the general formula (1) (wherein the definition of each group is as described in the specification) is provided. The compound represented by the general formula (1) has a strong opening action with respect to KCNQ2-5 channels, and therefore is useful as a prophylactic and/or therapeutic agent for a KCNQ2-5 channel-related disease (for example, dysuria, overactive bladder, or the like).
    Type: Application
    Filed: April 21, 2017
    Publication date: May 2, 2019
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kentaro YASHIRO, Masashi KATO, Tetsuji SAITO, Takuya OKADA, Daisuke WAKAMATSU, Adam James DAVENPORT, Christopher Charles STIMSON
  • Publication number: 20190043162
    Abstract: An information processing apparatus according to the present invention, includes: a first acquiring unit configured to acquire surface change information on magnitude of change of a projection surface onto which an image is projected; and a determining unit configured to determine, based on the surface change information, frame rate control information on a frame rate of image processing to allow the image to follow the projection surface.
    Type: Application
    Filed: July 24, 2018
    Publication date: February 7, 2019
    Inventor: Tetsuji Saito
  • Patent number: 10196358
    Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: February 5, 2019
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Kentaro Yashiro, Daisuke Wakamatsu, Tetsuji Saito
  • Publication number: 20180376011
    Abstract: An image processing apparatus comprises: a first generation unit that generates approximate light pattern by adjusting spatial frequency of an input image, and generates a projection image data based on the approximate light pattern; and a second generation unit that generates a print image data based on the input image, wherein the second generation unit generates the print image data so that a difference between the input image and an image for observation obtained by superimposing projection light projected based on the projection image data onto a printed matter printed based on the print image data is reduced.
    Type: Application
    Filed: June 20, 2018
    Publication date: December 27, 2018
    Inventors: Masanao Kurita, Shinya Oda, Masayoshi Sekine, Tetsuji Saito, Yasuo Suda
  • Publication number: 20180346422
    Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.
    Type: Application
    Filed: August 9, 2018
    Publication date: December 6, 2018
    Applicant: Ono Pharmaceutical Co., Ltd.
    Inventors: Kentaro Yashiro, Daisuke WAKAMATSU, Tetsuji SAITO
  • Publication number: 20180289718
    Abstract: The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA ?5) and act as GABAA ?5 negative allosteric modulators (GABAA ?5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA ?5 such as Alzheimer's disease.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 11, 2018
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Tetsuji SAITO, Masato HIGASHINO, Soichi KAWAHARADA, Arwel LEWIS, Mark Stuart CHAMBERS, Alastair RAE, Kim Louise HIRST, Charles David HARTLEY
  • Publication number: 20180204542
    Abstract: An image processing apparatus according to the present invention, includes: a determination unit configured to determine, based on a layout of at least one image included in display image data, a display correspondence, which is a correspondence between a gradation value of the display image data and a display brightness in a case where a display unit displays an image based on the display image data; and an output unit configured to output to the display unit the display image data and information indicating the display correspondence.
    Type: Application
    Filed: January 12, 2018
    Publication date: July 19, 2018
    Inventor: Tetsuji Saito
  • Patent number: 10016439
    Abstract: The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA ?5) and act as GABAA ?5 negative allosteric modulators (GABAA ?5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA ?5 such as Alzheimer's disease.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: July 10, 2018
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Tetsuji Saito, Masato Higashino, Soichi Kawaharada, Arwel Lewis, Mark Stuart Chambers, Alastair Rae, Kim Louise Hirst, Charles David Hartley